Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization

• Main Authors: Petrou P (Author), Georgalas I (Author), Markomichelakis N (Author), Vergados I (Author), Gianakaki E (Author), Rouvas A (Author)
• Format: Book
• Published: Dove Medical Press, 2013-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Petros Petrou,1,2 Ilias Georgalas,2 Nikolaos Markomichelakis,2 Ioannis Vergados,2 Emanuela Gianakaki,2 Alexander Rouvas21Moorfields Eye Hospital, London, UK; 2Ophthalmology Department, University of Athens, Athens, GreecePurpose: To present the occurrence of the resolution of vitreomacular traction following intravitreal ranibizumab in two patients with inflammatory choroidal neovascular (CNV) membrane with a background of ocular toxoplasmosis.Methods: Interventional case report.Results: A 21-year-old Caucasian woman and a 52-year-old Caucasian man both presented with vitreomacular traction with coexistent classic CNV membrane and a background of ocular toxoplasmosis. They both received an intravitreal injection of ranibizumab in an effort to control the underlying CNV membrane. A resolution of the vitreomacular traction was observed within 1 week of the intravitreal injection in both cases.Conclusion: To the best of our knowledge, this is the first reported case of vitreomacular traction resolution in two patients with ocular toxoplasmosis following ranibizumab administration. Of course, further studies are needed in order to adequately support this association.Keywords: vitreomacular traction, spontaneous resolution, ranibizumab, intravitreal, inflammation

Item Description

1176-6336
1178-203X